Resultados globales: 1 registros encontrados en 0.03 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
18 p, 451.1 KB EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies / Kiesewetter, B. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Cherny, N. I. (Cancer Pain and Palliative Medicine Service. Department of Medical Oncology. Shaare Zedek Medical Center) ; Boissel, Nicolas (Diderot University Paris Faculty of Medicine) ; Cerisoli, F. (European Hematology Association) ; Dafni, U. (Frontier Science Foundation-Hellas) ; De Vries, Elisabeth G. E. (Department of Medical Oncology. University Medical Center Groningen) ; Ghia, Paolo (Universita Vita e Salute San Raffaele) ; Gökbuget, N. (Department of Hematology/Oncology. Goethe University) ; González-Calle, Verónica (Instituto de Investigación Biomédica de Salamanca) ; Huntly, B. (Cambridge Stem Cell Institute. Department of Haematology. University of Cambridge) ; Jäger, U. (Department of Medicine i. Clinical Division of Hematology and Hemostaseology. Medical University of Vienna) ; Latino, N. J. (Head Office. European Society for Medical Oncology) ; Douillard, Jean-Yves (Head Office. European Society for Medical Oncology) ; Malcovati, Luca (Department of Hematology Oncology. Fondazione IRCCS Policlinico San Matteo) ; Mateos, M. V. (Instituto de Investigación Biomédica de Salamanca) ; Ossenkoppele, G. J. (Amsterdam Universitair Medische Centra (Amsterdam, Països Baixos)) ; Porkka, K. (Helsinki University Hospital (Finlàndia)) ; Raderer, M. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Scarfò, Lydia (Universita Vita e Salute San Raffaele) ; Wester, R. (Erasmus MC Cancer Institute (Rotterdam, Països Baixos)) ; Zygoura, P. (Frontier Science Foundation-Hellas) ; Sonneveld, P. (Department of Radiation Oncology. Erasmus MC Cancer Institute) ; Universitat Autònoma de Barcelona
Objective Value frameworks in oncology have not been validated for the assessment of treatments in haematological malignancies, but to avoid overlaps and duplications it appears reasonable to build up experience on existing value frameworks, such as the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS). [...]
2020 - 10.1136/esmoopen-2019-000611
ESMO open, Vol. 5 Núm. 1 (20 2020) , p. e000611  

Vea también: autores con nombres similares
1 Dafni, Urania
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.